Abbott Laboratories

Abbott Laboratories

18.68
CAD
-0.35
(-1.84%)
247.54BMarket Cap
Jan 27Next Earn

Total Valuation

CAD

As of September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged carries a market capitalization of 247.54B, placing it among publicly traded companies globally. Its enterprise value stands at 286.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap247.54B
Enterprise Value286.60B

Important Dates

Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged's next confirmed earnings release is scheduled for January 27, 2027.

Earnings Date1/27/2027

Share Statistics

As of September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged has 14.19B shares outstanding.

Shares Outstanding14.19B

Valuation Ratios

These figures are as of September 30, 2026.

PB Ratio3.41
P/TBV Ratio-144.14

Financial Position

As of September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged maintains a current ratio of 1.45, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

Current Ratio1.45
Quick Ratio1.00
Debt / Equity60.36

Financial Efficiency

These figures cover the twelve months ended September 30, 2026.

Employee Count115,000.00

Taxes

CAD

Over the twelve months ended September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged recorded 1.80B in income tax expense.

Income Tax1.80B

Stock Price Statistics

CAD

These figures are as of the close on November 12, 2026.

50-Day Moving Average18.46

Balance Sheet

CAD

As of September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged holds 6.12B in cash and equivalents against 44.33B in total debt, resulting in a net debt position of 38.57B. Total book value stands at 72.60B, with working capital of 10.45B providing operational flexibility.

Cash & Cash Equivalents6.12B
Total Debt44.33B
Net Debt38.57B
Equity (Book Value)72.60B
Book Value Per Share5.12
Working Capital10.45B

Cash Flow

CAD

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-2.28B

Dividends & Yields

CAD

Over the twelve months ended September 30, 2026, Abbott Laboratories Shs UnSponsored Canadian Depository Receipt Hedged paid dividends of 0.32 per share.

Dividend Per Share0.32